Your browser doesn't support javascript.
loading
A rare non-gadolinium enhancing sarcoma brain metastasis with microenvironment dominated by tumor-associated macrophages.
Rogawski, David; Wheeler, Joshua; Nie, Esther; Zhu, William; Villanueva, Eleanor; Coffey, Gwen; Ma, Qian; Ganjoo, Kristen; Fischbein, Nancy; Iv, Michael; Vogel, Hannes; Nagpal, Seema.
Afiliação
  • Rogawski D; Division of Neuro-Oncology, Stanford Medicine, Stanford, CA, 94305, USA. rogawski@stanford.edu.
  • Wheeler J; Division of Neuropathology, Department of Pathology, Stanford Medicine, Stanford, CA, 94305, USA.
  • Nie E; Division of Neuroimmunology, Stanford Medicine, Stanford, CA, 94305, USA.
  • Zhu W; Department of Neurology and Neurological Sciences, Stanford Medicine, Stanford, CA, 94305, USA.
  • Villanueva E; Division of Neuro-Oncology, Stanford Medicine, Stanford, CA, 94305, USA.
  • Coffey G; Division of Neuro-Oncology, Stanford Medicine, Stanford, CA, 94305, USA.
  • Ma Q; Department of Neurology and Neurological Sciences, Stanford Medicine, Stanford, CA, 94305, USA.
  • Ganjoo K; Division of Oncology, Department of Medicine, Stanford Medicine, Stanford, CA, 94305, USA.
  • Fischbein N; Division of Neuroradiology, Department of Radiology, Stanford Medicine, Stanford, CA, 94305, USA.
  • Iv M; Division of Neuroradiology, Department of Radiology, Stanford Medicine, Stanford, CA, 94305, USA.
  • Vogel H; Division of Neuropathology, Department of Pathology, Stanford Medicine, Stanford, CA, 94305, USA.
  • Nagpal S; Division of Neuro-Oncology, Stanford Medicine, Stanford, CA, 94305, USA.
Acta Neuropathol Commun ; 12(1): 15, 2024 01 22.
Article em En | MEDLINE | ID: mdl-38254244
ABSTRACT
Brain metastases occur in 1% of sarcoma cases and are associated with a median overall survival of 6 months. We report a rare case of a brain metastasis with unique radiologic and histopathologic features in a patient with low grade fibromyxoid sarcoma (LGFMS) previously treated with immune checkpoint inhibitor (ICI) therapy. The lone metastasis progressed in the midbrain tegmentum over 15 months as a non-enhancing, T2-hyperintense lesion with peripheral diffusion restriction, mimicking a demyelinating lesion. Histopathology of the lesion at autopsy revealed a rich infiltrate of tumor-associated macrophages (TAMs) with highest density at the leading edge of the metastasis, whereas there was a paucity of lymphocytes, suggestive of an immunologically cold environment. Given the important immunosuppressive and tumor-promoting functions of TAMs in gliomas and carcinoma/melanoma brain metastases, this unusual case provides an interesting example of a dense TAM infiltrate in a much rarer sarcoma brain metastasis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias Encefálicas / Glioma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Acta Neuropathol Commun Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias Encefálicas / Glioma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Acta Neuropathol Commun Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos